Trademarkia Logo

Canada

C$
Trademark Search in Canada
DAILY SPECIAL

View On IC.GC.CA

DAILY SPECIAL
REGISTERED

on 25 May 2022

Last Applicant/ Owned by

1770415 ALBERTA LTD.

c/o Suite 2800, 10104 103 Avenue NWEdmonton

ALBERTA

CA

T5J0H8

Serial Number

1998537 filed on 28th Nov 2019

Registration Number

TMA1129707 registered on 25th May 2022

Registration expiry Date

25th May 2032

Correspondent Address

FIELD LLP

213-304 Old Canmore RoadCanmore

ALBERTA

CA

T1W0L5

DAILY SPECIAL

Trademark usage description

non-medicinal topical products, namely oils and concentrated pastes, namely massage creams, massage oils, bath oil, body oils, cosmetic oils, oils for Read More

Classification Information

Class [003]
Non-medicinal topical products, namely oils and concentrated pastes, namely massage creams, massage oils, bath oil, body oils, cosmetic oils, oils for toiletry purposes, skin creams, skin lotions, lip care preparations, face and body lotions, bath additives, soaps for personal use, beauty creams for body care, non-medicated skin preparations; oils for cosmetic purposes; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused non-medicinal topical products, namely oils and concentrated pastes, namely massage creams, massage oils, bath oil, body oils, cosmetic oils, oils for toiletry purposes, skin creams, skin lotions, lip care preparations, face and body lotions, bath additives, soaps for personal use, beauty creams for body care, non-medicated skin preparations; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for cosmetic purposes; cleaning solutions for oral vaporizers for smoking

Classification kind code

11

Class [005]
Medicines, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives; medicines for temporary relief of seizures; medicines for the relief of nausea caused by chemotherapy; medicines for the relief of nerve pain; medicines for the treatment of muscle spasms caused by multiple sclerosis; nutraceuticals and herbs for medicinal purposes, oils, salves, concentrated pastes, tinctures, tablets and capsules, all the aforementioned products for the relief of pain and treatment in palliative care, for reducing stress and fatigue, for mood enhancement, for relief from nausea, vomiting, headaches, muscle spasms, seizures, wasting syndrome and loss of appetite in AIDS and cancer patients, for maintaining general health and well-being, for treating symptoms associated with anorexia nervosa, Crohn's disease, multiple sclerosis, amyotrophic lateral sclerosis, fibromyalgia, spinal cord injury, epilepsy, migraines, arthritides and musculoskeletal disorders, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, rheumatism, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, epilepsy, convulsant and movement disorders, cervical dystonia, Meige's syndrome, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, attention and hyperactivity disorders, Alzheimer's disease, and dementia, for the treatment of, and symptoms associated with, skin infections and irritations, namely bacterial skin infections, dermatitis, atrophie blanche, eczema, burns, rashes from skin allergies and reactions, psoriasis, pruritis and neuropathic pain, for the treatment of, and relief of symptoms associated with, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, Wilson's disease, metabolic syndrome, obesity, diabetes, diseases of the pancreas, neoplasia, and atherosclerosis, osteoarthritis, and osteoporosis, and all the aforementioned products as anti-inflammatories, anti-viral enzyme activators, analgesics, sedatives, appetite stimulants and anti-emetics, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antibacterials, antidepressants and antihypertensives; oils for the treatment of cancer; cannabidiol [CBD] oil for medical purposes; Cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives; cannabis-based, cannabis infused, cannabinoid-based and cannabinoid-infused medicines for temporary relief of seizures; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the relief of nausea caused by chemotherapy; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the relief of nerve pain; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the treatment of muscle spasms caused by multiple sclerosis; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused nutraceuticals and herbs for medicinal purposes, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils, salves, concentrated pastes, tinctures, tablets and capsules, all the aforementioned products for the relief of pain and treatment in palliative care, for reducing stress and fatigue, for mood enhancement, for relief from nausea, vomiting, headaches, muscle spasms, seizures, wasting syndrome and loss of appetite in AIDS and cancer patients, for maintaining general health and well-being, for treating symptoms associated with anorexia nervosa, Crohn's disease, multiple sclerosis, amyotrophic lateral sclerosis, fibromyalgia, spinal cord injury, epilepsy, migraines, arthritides and musculoskeletal disorders, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, rheumatism, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, epilepsy, convulsant and movement disorders, cervical dystonia, Meige's syndrome, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, attention and hyperactivity disorders, Alzheimer's disease, and dementia, for the treatment of, and symptoms associated with, skin infections and irritations, namely bacterial skin infections, dermatitis, atrophie blanche, eczema, burns, rashes from skin allergies and reactions, psoriasis, pruritis and neuropathic pain, for the treatment of, and relief of symptoms associated with, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, Wilson's disease, metabolic syndrome, obesity, diabetes, diseases of the pancreas, neoplasia, and atherosclerosis, osteoarthritis, and osteoporosis, and all the aforementioned products as anti-inflammatories, anti-viral enzyme activators, analgesics, sedatives, appetite stimulants and anti-emetics, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antibacterials, antidepressants and antihypertensives; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for the treatment of cancer; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for medical purposes

Classification kind code

11

Class [022]
Hemp

Classification kind code

11

Class [029]
Spreadable food products, namely, almond butter, apple butter, butter, cashew nut butter, chocolate nut butter, cocoa butter, coconut butter, peanut butter, seed butters, soy-based butter substitute, honey butter, garlic butter, butter cream; cannabis-based, cannabis-infused, cannabinoid based and cannabinoid-infused spreadable food products, namely, almond butter, apple butter, butter, cashew nut butter, chocolate nut butter, cocoa butter, coconut butter, peanut butter, seed butters, soy based butter substitute, honey butter, garlic butter, butter cream; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused edible oils; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for food; cannabis extracts for food

Classification kind code

11

Class [030]
Food products, namely chocolates, chocolate bars, cookies, brownies, mints infused with cannabis, gum, candy and food energy bars, ice cream, ice cream bars, ice cream cones, sorbet, edible ices; baked goods, namely, cookies, brownies and pastries; teas; sauces, namely, apple sauce, barbeque sauce, hot sauce, pizza sauce, pasta sauce, cheese sauce, tomato sauce, sauce mixes; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused food products, namely chocolates, chocolate bars, cookies, brownies, mints infused with cannabis, gum, candy and food energy bars, ice cream, ice cream bars, ice cream cones, sorbet, edible ices; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused baked goods, namely, cookies, brownies and pastries; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused teas; cannabis-based, cannabis infused, cannabinoid-based and cannabinoid-infused sauces, namely, apple sauce, barbeque sauce, hot sauce, pizza sauce, pasta sauce, cheese sauce, tomato sauce, sauce mixes

Classification kind code

11

Class [032]
Non-alcoholic beverages and drinks, namely smoothies, fruit beverages, fruit juices, vegetable juices, carbonated soft drinks, energy drinks, carbonated water, frozen fruit juices, fruit-flavored beverages, coffee-based beverages, tea-based beverages, beer; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused non-alcoholic beverages and drinks, namely smoothies, fruit beverages, fruit juices, vegetable juices, carbonated soft drinks, energy drinks, carbonated water, frozen fruit juices, fruit-flavored beverages, coffee-based beverages, tea based beverages, beer

Classification kind code

11

Class [034]
Dried cannabis; dried marijuana; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for electronic cigarettes; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for oral vaporizers for smoking; smoker's articles, namely, rolling papers, pipes, vaporizers and grinders; cannabis grinders; smoking herb grinders; marijuana grinders

Classification kind code

11

Class [035]
A product ordering service, namely a product ordering service whereby medical marijuana patients can order cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused products and medicines using a smartphone device; Retail, wholesale, and online sales of dried cannabis, live cannabis plants, dried marijuana, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused products and medicines for temporary relief of seizures, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the relief of nausea caused by chemotherapy, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the relief of nerve pain, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the treatment of muscle spasms caused by multiple sclerosis, herbal vaporizers, oral vaporizers for smoking purposes, rolling kits for smoking, rolling papers, herbal grinders, herbal scissors, apparel, namely, casual clothing, hats, baseball caps, t-shirts

Classification kind code

11

Mark Details

Serial Number

1998537

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 7th Jan 2022		Approved
Submitted for opposition 27
on 7th Jan 2022		Approval Notice Sent
Submitted for opposition 135
on 2th Dec 2021		Amendment to Application
Submitted for opposition 135
on 7th May 2021		Amendment to Application
Submitted for opposition 12
on 21st Apr 2021		Extension of Time
Submitted for opposition 20
on 17th Sept 2020		Examiner's First Report
Submitted for opposition 22
on 9th Sept 2020		Search Recorded
Submitted for opposition 31
on 10th Dec 2019		Formalized
Submitted for opposition 1
on 29th Nov 2019		Created
Submitted for opposition 30
on 28th Nov 2019		Filed